Resistance to the Antitumor Agent Gallium Nitrate in Human Leukemic Cells Is Associated with Decreased Gallium/Iron Uptake, Increased Activity of Iron Regulatory Protein-1, and Decreased Ferritin Production

This publication has 40 references indexed in Scilit:

• Iron Regulates the Intracellular Degradation of Iron Regulatory Protein 2 by the Proteasome
  Journal of Biological Chemistry, 1995
• Regulation of Iron Metabolism: Translational Effects Mediated by Iron, Heme, and Cytokines
  Annual Review of Nutrition, 1995
• Iron regulatory elements (IREs): a family of mRNA non-coding sequences
  Biochemical Journal, 1994
• Regulatory effects of gallium on transferrin-independent iron uptake by human leukemic HL60 cells
  Blood, 1992
• Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors
  Cancer, 1991
• Inhibition of leukemic HL60 cell growth by transferrin-gallium: effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea [see comments]
  Blood, 1988
• Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5' untranslated region of ferritin heavy- and light-subunit mRNAs.
  Proceedings of the National Academy of Sciences, 1988
• Effects of different transferrin forms on transferrin receptor expression, iron uptake, and cellular proliferation of human leukemic HL60 cells. Mechanisms responsible for the specific cytotoxicity of transferrin-gallium.
  Journal of Clinical Investigation, 1986
• Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion
  Cancer, 1983
• Thermodynamic binding constants for gallium transferrin
  Biochemistry, 1983